Ongoing genomic surveillance by the WHO and CDC shows no SARS-CoV-2 lineages currently meeting the criteria for a variant of concern, with dominant strains remaining sublineages of JN.1 such as XFG and monitored variants like NB.1.8.1 and the more recently designated PQ.16.1.1. BA.3.2, first flagged as a variant under monitoring in late 2025, has circulated in multiple countries without evidence of substantially higher severity or immune escape that would trigger escalation. Widespread population immunity from prior infections and updated vaccines continues to limit the public health impact of new mutations, while health authorities emphasize routine tracking over urgent alerts. These stable conditions underpin trader consensus favoring no new designation of concern before 2027, though continued evolution warrants close monitoring through year-end.